Anti-angiogenetic agents against tumor types and cardiovascular risk

Hellenic J Cardiol. 2017 May-Jun;58(3):220-222. doi: 10.1016/j.hjc.2017.08.005. Epub 2017 Aug 24.

Authors

Panagiota Economopoulou¹, Ioannis Kotsantis¹, Amanda Psyrri²

Affiliations

¹ 2nd Department of Internal Medicine, Section of Medical Oncology, Attikon University Hospital, National Kapodistrian University of Athens, Athens, Greece.
² 2nd Department of Internal Medicine, Section of Medical Oncology, Attikon University Hospital, National Kapodistrian University of Athens, Athens, Greece. Electronic address: psyrri237@yahoo.com.

PMID: 28844944
DOI: 10.1016/j.hjc.2017.08.005

No abstract available

Publication types

Editorial
Comment

MeSH terms

Angiogenesis Inhibitors*
Cardiovascular Diseases*
Humans
Neoplasms
Risk Factors

Substances

Angiogenesis Inhibitors